The Chief Marketing Officer of a prescription digital therapeutics (PDT) company was seeking to prepare the organization for future launches. Read how Vynamic leveraged both Healthcare Technology and Life Sciences expertise to build a detailed, practical launch playbook used to expand commercialization in both products and patient types.
Prescription Digital Therapeutics (PDTs) are a new but rapidly growing category of treatments. The Chief Marketing Officer of a PDT company wanted to position the organization to maximize future launches. To do this, they asked Vynamic to assess best practices from the company’s first launch and recommend improvements for future launches based on Vynamic’s launch experience. Launching a PDT presents a unique set of challenges, and the client teams’ mix of big pharma and technology experience required an especially nuanced approach.
PDT launches differ from traditional pharmaceutical launches in several key ways, including regulatory pathway, funding cycles, the role of the Product team, and reimbursement strategies. Vynamic leveraged our launch experience and partnered with the client’s Commercial, Medical, and Product teams to develop a launch excellence playbook tailored to the unique needs of our PDT client.
The Vynamic team took the following approach:
Assess Opportunities & Recommendations
Define the Key Decisions
Establish the Governance Framework
Develop the Project Plan
Leveraging our unique market experience across Healthcare Technology and Life Sciences, the Vynamic team created a playbook that impacted the ways the organization’s functions interact and collaborate. The client uses this playbook to ensure consistent application of launch best practices that are agile and scalable. As a result of this initial project, the client also engaged Vynamic to drive its next commercial launch and several other strategic projects.
Contact our team to learn more about how we can help your needs.
Send us a message and we'll get back to you shortly.
"*" indicates required fields